Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.
Emergingsuggested applicable standard· American Association for the Study of Liver Diseases, 'Guidelines on the Management of Adult Patients with Ascites Due to Cirrhosis', 2021
American Association for the Study of Liver Diseases, 'Guidelines on the Management of Adult Patients with Ascites Due to Cirrhosis', 2021 · reviewed 2026-07-21 ↗Perform diagnostic paracentesis in any cirrhotic with ascites and infection risk; an ascitic PMN ≥250 cells/μL diagnoses SBP and mandates empiric IV antibiotics ASAP, ceftriaxone 2 g IV daily for community-acquired disease (broader pip-tazo/carbapenem for nosocomial). Administer albumin (1.5 g/kg day 1, 1 g/kg day 3) to patients with serum creatinine >1 mg/dL, BUN ≥30 mg/dL, or bilirubin ≥4 mg/dL to reduce HRS and mortality. Confirm response with a repeat paracentesis at 48 h (adequate = PMN drop ≥25%), distinguish secondary peritonitis by Runyon criteria, and start indefinite secondary prophylaxis (norfloxacin/ciprofloxacin/TMP-SMX) after an episode.